Online Weight Loss Giveaways Promote Unlicensed Medicines as Prizes
A growing number of social media groups are using giveaways and competitions to promote powerful, unlicensed medicines for weight loss. These online contests often appear as legitimate fitness or coaching opportunities but secretly offer experimental treatments that haven't been approved for medical use anywhere in the world.
One example is a WhatsApp group called BioUK Research peptides 2, which has over 1,000 members and claims to be offering an "ultimate peptide stack" including retatrutide, a weight loss drug currently undergoing clinical trials. The group promises next-day delivery of these unlicensed medicines, often masquerading as prizes in giveaways or raffles.
Regulators warn that these digital marketing techniques applied to pharmaceuticals without licenses in the UK are extremely dangerous. Unlicensed medicines carry serious health risks due to lack of safety checks and quality control measures. Moreover, their sale may breach medicines regulations.
In another case, a fitness company called BioBlue Cosmetics is operating as a front for unlicensed weight loss drugs under the guise of exercise programs. The website appears legitimate at first but reveals its true intention when contacted by potential customers. This company uses coded language to communicate with users about the purchase of retatrutide and other experimental treatments.
Experts say that such tactics are not only unethical but also have serious consequences for public health. "Giveaways, countdown timers, and raffles are classic pressure tactics designed to override caution," says Emily Rickard, a research fellow at the University of Bath. "Using these tactics to promote powerful unlicensed injectable drugs is extremely dangerous."
Regulators and social media companies must work together to crack down on such deceptive marketing practices and protect consumers from falling victim to online scams that put their health at risk.
In response to these findings, Meta has stated that it will ban accounts breaking its messaging guidelines and Telegram has removed content related to the sale of illegal medication. However, more needs to be done to address this growing issue and ensure public safety online.
As concerns about unlicensed medicines and digital marketing tactics continue to grow, regulators must stay vigilant in their efforts to regulate these activities and protect consumers from harm.
A growing number of social media groups are using giveaways and competitions to promote powerful, unlicensed medicines for weight loss. These online contests often appear as legitimate fitness or coaching opportunities but secretly offer experimental treatments that haven't been approved for medical use anywhere in the world.
One example is a WhatsApp group called BioUK Research peptides 2, which has over 1,000 members and claims to be offering an "ultimate peptide stack" including retatrutide, a weight loss drug currently undergoing clinical trials. The group promises next-day delivery of these unlicensed medicines, often masquerading as prizes in giveaways or raffles.
Regulators warn that these digital marketing techniques applied to pharmaceuticals without licenses in the UK are extremely dangerous. Unlicensed medicines carry serious health risks due to lack of safety checks and quality control measures. Moreover, their sale may breach medicines regulations.
In another case, a fitness company called BioBlue Cosmetics is operating as a front for unlicensed weight loss drugs under the guise of exercise programs. The website appears legitimate at first but reveals its true intention when contacted by potential customers. This company uses coded language to communicate with users about the purchase of retatrutide and other experimental treatments.
Experts say that such tactics are not only unethical but also have serious consequences for public health. "Giveaways, countdown timers, and raffles are classic pressure tactics designed to override caution," says Emily Rickard, a research fellow at the University of Bath. "Using these tactics to promote powerful unlicensed injectable drugs is extremely dangerous."
Regulators and social media companies must work together to crack down on such deceptive marketing practices and protect consumers from falling victim to online scams that put their health at risk.
In response to these findings, Meta has stated that it will ban accounts breaking its messaging guidelines and Telegram has removed content related to the sale of illegal medication. However, more needs to be done to address this growing issue and ensure public safety online.
As concerns about unlicensed medicines and digital marketing tactics continue to grow, regulators must stay vigilant in their efforts to regulate these activities and protect consumers from harm.